| By aan.com,
on 17-09-2008 14:42
|
Favoured : 1 |
GORDONSVILLE, Va., Sept. 17 /PRNewswire/ -- Vitamin B12 may protect the
brain in old age and reduce risk of dementia, according to a new study by
University of Oxford researchers. Published in the new issue of Neurology,
the study determined people with higher blood levels of vitamin B12 were
six times less likely to experience brain shrinkage compared with people
with lower vitamin levels.
According to study author Anna Vogiatzoglou, MSc, University of Oxford,
the study suggests consuming more vitamin B12 to prevent brain shrinkage
may save memory.
"Research shows that vitamin B12 deficiency is a public health problem,
especially among the elderly, so more vitamin B12 intake could help reverse
this problem," said Vogiatzoglou.
Doctors are prescribing Animi-3(R) to address nutritional deficiencies
including vitamin B12 and other essential nutrients to deficient patients.
Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 1 mg
of folic acid, 12.5 mg of B6, and 12 mcg of B12.
"This Oxford University study correlates with other clinical findings
that point to specific nutrient deficiencies correlated with reduced brain
function," said Jack Schramm, President of PBM Pharmaceuticals, the makers
of Animi-3. "Studies continue to highlight the role nutritional
deficiencies of the Animi-3 nutrients play in those with diminished brain
health."
Dr. Schaefer, M.D., Tufts University, has analyzed the relationship
of DHA to dementia and Alzheimer's disease. His observations from the
Framingham Heart Study indicate top quartile plasma DHA levels (correlated
with consuming 180 mg/day or more of DHA) are associated with a 50%
decreased risk of dementia.
Fernando Gomez-Pinilla, UCLA professor of neurosurgery and
physiological science, identified nutrients beneficial in preventing mental
disorders, including omega-3 (DHA), folic acid, and vitamins B6 and B12.
Omega-3 deficiency has been associated with increased risk of
attention-deficit disorder, dyslexia, dementia, depression, bipolar
disorder, and schizophrenia.
Dr. Jane Durga, Wageningen University, published findings from a
double-blind, placebo-controlled study in The Lancet that determined
cognitive function improved significantly in participants taking folic
acid.
More information on Animi-3 ingredients is found on
http://www.animi-3.com and on http://www.dhaandbvitamins.org, a resource
developed by specialists at Weill Cornell Medical College and other medical
centers.
Animi-3 is not intended to diagnose, treat, or cure any disease.
Source:
http://www.aan.com/press/index.cfm?fuseaction=release.view&release=652
Contact: Joe Shields
Director of Public Relations
(800) 959-2066 ext. 1131
jshields@pbmproducts.com
Last update : 18-09-2008 00:19
|
|
|
Home 
Index 
